Greg Jensen
2021
In 2021, Greg Jensen earned a total compensation of $954.9K as Former Vice President, Finance and Chief Financial Officer at Xtant Medical Holdings, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $100,200 |
|---|---|
| Option Awards | $206,543 |
| Salary | $393,846 |
| Stock Awards | $198,438 |
| Other | $55,883 |
| Total | $954,910 |
Jensen received $393.8K in salary, accounting for 41% of the total pay in 2021.
Jensen also received $100.2K in non-equity incentive plan, $206.5K in option awards, $198.4K in stock awards and $55.9K in other compensation.
Rankings
In 2021, Greg Jensen's compensation ranked 8,930th out of 12,405 executives tracked by ExecPay. In other words, Jensen earned more than 28.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,930 out of 12,405 | 28th |
Division Manufacturing | 3,956 out of 5,494 | 28th |
Major group Chemicals And Allied Products | 1,737 out of 2,369 | 27th |
Industry group Drugs | 1,545 out of 2,090 | 26th |
Industry Biological Products, Except Diagnostic Substances | 338 out of 452 | 25th |
Source: SEC filing on September 20, 2022.
Jensen's colleagues
We found two more compensation records of executives who worked with Greg Jensen at Xtant Medical Holdings in 2021.